Karen E. Bowker
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 51
-
- Antibiotic Use and Resistance 17
- Co-authors
- Alasdair MacGowanAlan NoelH. A. HoltMandy WoottonChris RogersMahableshwar AlburDavid S. ReevesG.C. Bannister
- Journals
- Journal of Antimicrobial Chemotherapy (30 papers)Antimicrobial Agents and Chemotherapy (21 papers)International Journal of Antimicrobial Agents (9 papers)Journal of Hospital Infection (7 papers)Journal of Chemotherapy (3 papers)
- Partner nations
- United KingdomChinaAustralia
In The Last Decade
Karen E. Bowker
89 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 114
- Molecular Medicine 804
- Applied Microbiology and Biotechnology 207
- Pharmacology 888
- Clinical Biochemistry 270
- Infectious Diseases 420
Countries citing papers authored by Karen E. Bowker
This map shows the geographic impact of Karen E. Bowker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen E. Bowker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen E. Bowker more than expected).
Fields of papers citing papers by Karen E. Bowker
This network shows the impact of papers produced by Karen E. Bowker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen E. Bowker. The network helps show where Karen E. Bowker may publish in the future.
Co-authors
The 25 scholars most cited alongside Karen E. Bowker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2021 | 12 | |
| 3 | 2020 | 8 | |
| 4 | 2019 | 38 | |
| 5 | 2019 | 14 | |
| 6 | 2019 | 11 | |
| 7 | 2019 | 7 | |
| 8 | 2019 | 4 | |
| 9 | 2018 | 15 | |
| 10 | 2017 | 22 | |
| 11 | 2016 | 3 | |
| 12 | 2015 | 50 | |
| 13 | Pharmacodynamics of Telavancin: Relationship of AUC/MIC to Antibacterial Effect and Emergence of Resistance | 2008 | 2 |
| 14 | 2006 | 28 | |
| 15 | 2000 | 11 | |
| 16 | 1999 | 28 | |
| 17 | 1999 | 18 | |
| 18 | 1999 | 41 | |
| 19 | 1996 | 19 | |
| 20 | 1994 | 117 |
About Karen E. Bowker
Karen E. Bowker is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Pharmacology, Clinical Biochemistry and Infectious Diseases, having authored 89 papers that have together received 1.9k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (58 papers), Antibiotic Resistance in Bacteria (51 papers), Pneumonia and Respiratory Infections (22 papers), Antibiotic Use and Resistance (17 papers), Antimicrobial Resistance in Staphylococcus (16 papers), Bacterial Identification and Susceptibility Testing (14 papers), Surgical site infection prevention (9 papers) and Pressure Ulcer Prevention and Management (4 papers). The work is most often cited by research in Molecular Medicine (804 citations), Applied Microbiology and Biotechnology (207 citations), Pharmacology (888 citations), Clinical Biochemistry (270 citations) and Infectious Diseases (420 citations). Karen E. Bowker has collaborated with scholars based in United Kingdom, China and Australia. Frequent co-authors include Alasdair MacGowan, Alan Noel, H. A. Holt, Mandy Wootton, Chris Rogers, Mahableshwar Albur, David S. Reeves, G.C. Bannister, Ashley Blom and Peter M. Bennett. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, International Journal of Antimicrobial Agents, Journal of Hospital Infection and Journal of Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.